Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1)

The efficacy of cancer immunotherapy, including treatment with immune-checkpoint inhibitors, often is limited by ineffective presentation of antigenic peptides that elicit T-cell-mediated anti-tumor cytotoxic responses. Manipulation of antigen presentation pathways is an emerging approach for enhanc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Immunol Immunother
Egile Nagusiak: Koumantou, Despoina, Barnea, Eilon, Martin-Esteban, Adrian, Maben, Zachary, Papakyriakou, Athanasios, Mpakali, Anastasia, Kokkala, Paraskevi, Pratsinis, Harris, Georgiadis, Dimitris, Stern, Lawrence J., Admon, Arie, Stratikos, Efstratios
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6684451/
https://ncbi.nlm.nih.gov/pubmed/31222486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02358-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak